Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage Cell Therapeutics (LCTX) Goodwill: 2019-2024

Historic Goodwill for Lineage Cell Therapeutics (LCTX) over the last 6 years, with Dec 2024 value amounting to $10.7 million.

  • Lineage Cell Therapeutics' Goodwill changed negligibly% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $10.7 million for FY2024, which is negligibly% changed negligibly from last year.
  • Latest data reveals that Lineage Cell Therapeutics reported Goodwill of $10.7 million as of FY2024, which was down 0.00% from $10.7 million recorded in FY2023.
  • In the past 5 years, Lineage Cell Therapeutics' Goodwill ranged from a high of $10.7 million in FY2020 and a low of $10.7 million during FY2020.
  • Moreover, its 3-year median value for Goodwill was $10.7 million (2024), whereas its average is $10.7 million.